Hetal Gogri Gala
#618Vice Chairperson & Managing Director
49
Age
24y
Exp
24y
Tenure
5/10
Risk
🎓 Electronics Engineering · Mumbai University
🏛️ None
CompensationTBP
Personality
5
Open
7
Cons
4
Extr
5
Agre
4
Neur
Aarti Pharma
Healthcare · Mid Cap
High Growth · Innovation-Led
About
Hetal Gogri Gala is the Vice Chairperson & Managing Director of Aarti Pharma, a Mid Cap company in the Healthcare sector with a market cap of ₹6K Cr. A Pragmatic leader with 24 years of experience, she is known for consensus-driven decision-making and organic builder strategy. Emphasizes long-term manufacturing stability and integration within the pharma supply chain.
FAQ
What is Hetal Gogri Gala's leadership style?
Hetal Gogri Gala is classified as a Pragmatic leader. She is consensus-driven in decision-making, with a dynasty builder motivation and steady-marathon pace of execution.
What is Hetal Gogri Gala's educational background?
Hetal Gogri Gala holds a Electronics Engineering from Mumbai University.
Who is the CEO of Aarti Pharma?
Hetal Gogri Gala is the Vice Chairperson & Managing Director of Aarti Pharma. She has been with the company for 24 years and in the current role for 24 years.
Leadership DNA
ArchetypePragmatic
MotivationDynasty Builder
CrisisSteady Hand
DecisionConsensus-Driven
GrowthOrganic Builder
PeopleRelationship Led
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployerLearning Ground
BrandTechnical-Expert
FocusOperational Excellence
OrientationDeep Specialist
Leadership Evidence
“Emphasizes long-term manufacturing stability and integration within the pharma supply chain.”
⚡ Crisis●●●●○
Aarti Pharma's track record shows a consistent focus on operational stability and incremental improvements rather than radical restructuring or aggressive pivots during industry volatility.
🎯 Motivation●●●●●
As a key member of the promoter family, she has been instrumental in the strategic transition and long-term positioning of Aarti Pharma within the family's broader industrial ecosystem.
👥 People●●●○○
Her consensus-driven leadership style emphasizes stability and long-term internal cohesion characteristic of established family-led Indian enterprises.
📈 Growth●●●●○
The company's growth has been primarily driven by capacity expansion and strengthening its core manufacturing and R&D capabilities in the specialty chemical and pharma space.
💡 Innovation●●●●○
The company focuses on high-value niche APIs and complex generics, scaling production of existing molecules rather than pioneering new drug discovery.
🏃 Pace●●●●○
The business model relies on long-term supply chain integration and consistent capacity expansion rather than volatile, high-frequency product launches.
🌱 Purpose●●●○○
The company integrates ESG disclosures and sustainability initiatives into its annual reports alongside its financial growth strategy.
🏷️ Brand●●●●●
The company is defined by its reputation for high-quality chemical synthesis and process engineering capabilities within the global pharmaceutical supply chain.
🤝 Customer●●●●●
It primarily operates as a B2B supplier of Active Pharmaceutical Ingredients (APIs) and intermediates to global pharmaceutical companies.
💼 Employer●●●○○
As a specialized chemical and pharma manufacturer, it is recognized for building deep technical expertise in complex chemistry processes.
📋 Mandate
To move up the value chain from basic APIs to complex, high-margin niche molecules, the firm needs a leader focused on R&D acceleration.
🏢 Culture●●●○○
High-growth pharma specialty business requiring R&D focus, scientific agility, and a culture centered on complex chemical product development.
Financials
Revenue FY25₹2K Cr
PAT FY25₹272 Cr
Rev CAGR 5Y20.5%
OPM18.1%
NPM13.1%
ROE13.7%
ROCE16.8%
P/E27.6
Fwd P/E—
P/B2.9
D/E33
Promoter42.6%
Institutional12%
Mkt Cap₹6K Cr
Compensation
To Be Published
Data being verified from audited reports
